Getting Wegovy on the NHS: the real picture in 2025–26

You've been told Wegovy is available on the NHS, here's the full story

Imagine you've read that semaglutide is now available through the NHS and you've asked your GP about it. They may have pointed you toward a specialist referral. That referral is the first filter: under NICE TA875, Wegovy is recommended only when prescribed within a specialist weight management service that also provides dietary guidance, physical activity support and behavioural change input. A GP writing a private prescription is a different thing entirely, on the NHS, the medicine must sit inside that wraparound structure.

The clinical threshold is also more specific than most coverage suggests. NICE TA875 recommends semaglutide for adults with a BMI of 35 or above and at least one weight-related health condition, or for those with a BMI of 30–34.9 who meet specialist-referral criteria. For people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, these BMI thresholds are set 2.5 kg/m² lower. That is still a narrower window than the licensed eligibility for private prescription, which goes down to a BMI of 27 with a qualifying condition. You can look at the BMI thresholds for NHS Wegovy in more detail if you want the numbers side by side.

And even if you meet the numbers, you'll need to wait. Tier 3 and 4 specialist services are the only NHS commissioning pathway for Wegovy, and their waiting times vary widely. Some areas have lists measured in months; others are longer. That gap between qualifying on paper and actually starting treatment is the lived experience for a large number of people.

The two-year limit and what happens afterwards

One aspect of the NHS Wegovy pathway that surprises people is the treatment cap. NICE TA875 specifies a maximum of two years of treatment through the NHS. After that, the medicine is stopped. The guidance also includes a review point at six months: if someone on the maintenance dose has not achieved at least 5% weight loss by then, continuing is not considered cost-effective and treatment is reviewed.

This is worth knowing before you start, because semaglutide works partly through sustained use alongside lifestyle changes. Stopping after two years does not mean the work is finished. For some people, continued private treatment becomes a consideration at that point; for others, the lifestyle changes embedded during NHS treatment carry the weight. Either way, understanding that the NHS pathway has a defined end date is part of making an informed choice about getting Wegovy on the NHS versus through a private prescriber.

The question of whether an NHS GP can prescribe Wegovy outside a specialist service is one our prescribers hear regularly. The short answer is that the NICE recommendation is linked to specialist services, so the standard primary care route does not apply here in the way it does for, say, blood pressure medication.

Private prescription as the alternative, what that route looks like

For adults who meet the licensed eligibility criteria but are sitting on a waiting list, or whose BMI falls in the 27–34.9 range with a qualifying condition, a private prescription is the practical route to starting. The licensed criteria for private supply are set by the medicine's UK marketing authorisation: adults with a BMI of 30 or above, or 27–29.9 with at least one weight-related condition such as high blood pressure, raised cholesterol, type 2 diabetes or obstructive sleep apnoea.

At a regulated online pharmacy like ours, the process starts with a free consultation reviewed the same day by a GPhC-registered Independent Prescriber, a named clinician who reads your answers, not software running a screen. If treatment is clinically appropriate, your prescription is issued and your order dispatched the same day you order before noon. Your pen arrives the next working day via DPD, tracked to your door in plain, unmarked packaging. You can look at what private Wegovy costs on our pricing page, where everything included in the price is listed clearly.

The private route has no two-year ceiling built in by NICE. Each repeat order at nume is clinically re-reviewed, no auto-renewals, no subscriptions. If you are ready to begin, you can buy the Wegovy starting dose of 0.25mg directly through our prescriber-reviewed process. You can read more about how to get Wegovy through a private prescription or explore what the medicine involves before starting a consultation.

Red flags to watch when sourcing Wegovy outside the NHS

The same demand that creates NHS waiting lists also drives an illegal market. The MHRA has seized approximately 20 million doses of illegally traded weight-loss medicines (roughly £45 million in street value) and in October 2025 raided the first known UK site manufacturing counterfeit tirzepatide pens. Fake pens sold through social media and unregistered websites have in some cases contained insulin, causing serious harm.

Any supplier offering Wegovy without a prescription from a registered prescriber is operating outside the law. The safe check is straightforward: look up any online pharmacy on the GPhC register. A registered pharmacy has a premises registration number you can verify. If you cannot find a pharmacy on the register, do not order from them. Suspect sellers can be reported directly through the MHRA Yellow Card scheme, which also accepts reports of side effects. Our pharmacy's registration is publicly listed and verifiable at any time.

If you're weighing your options and want a clinical view on suitability, our team is here. Speak to our prescribers through a free consultation, no waiting list, reviewed the same day.